Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts.
Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.
Kratos Defense (KTOS) – This is a defense technology company specializing in drones, missile systems, and advanced military solutions. Today, Jefferies analyst Sheila Kahyaoglu upgraded the rating to Buy from Hold and maintained an $85 price target, citing a $14B opportunity pipeline in areas like Prometheus and hypersonics. She expects this to drive over 30% annual revenue growth to $2.4B by 2028, with Valkyrie production set to ramp to 35–45 units per year by 2027 from about 8 currently. Interestingly, nine out of the 11 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 58.46%.
Satellos Bioscience (MSLE) – This is a biotech company developing muscle regeneration therapies for diseases like Duchenne muscular dystrophy. Today, Leerink Partners analyst Joseph Schwartz maintained a Buy rating on the stock with a price target of $20 per share. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 166.89%.
Futu Holdings (FUTU) – Futu Holdings is a fintech company offering digital brokerage and trading services. Today, Bank of America Securities analyst Emma Xu maintained a Buy rating on the stock with a price target of $235 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 52.57%.